The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.25
Bid: 4.00
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.50 (12.50%)
Open: 4.25
High: 4.25
Low: 4.25
Prev. Close: 4.25
TAVI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of options

15 Jun 2021 12:55

RNS Number : 9737B
Tavistock Investments PLC
15 June 2021
 

 

Tavistock Investments Plc

("Tavistock", the "Group" or the "Company")

 

Grant of options

 

15 June 2021

 

Tavistock, the financial services group, announces that it has granted share options, with an exercise price of 5.25p per share, over an aggregate total of 70,000,000 shares (representing 11.5% of the Company's current issued share capital) to its Executive Directors, being Oliver Cooke and Brian Raven. The exercise price of these options has been set at a level that represents a premium of 11 per cent. over the Company's closing mid-market price on 14 June 2021. 40,000,000 of the options are being issued to Brian Raven and 30,000,000 are being issued to Oliver Cooke. The options are capable of immediate exercise, have no performance conditions and are not being issued under the Company's EMI Scheme.

 

Background

The Company recently attempted to introduce a new growth share incentive arrangement to replace the use of share options as a means of incentivising the Executive Directors and the Company's senior managers. The reason for seeking such a change was to avoid the share-based payment charges that adversely impact the Company's reported financial performance and consequently, in the opinion of the Board, also adversely impact the share price.

Having consulted with a number of the Company's larger shareholders and received assurances from them that they would vote in favour of the introduction of the new growth share incentive arrangements, the Executive Directors, on 1 March 2021, surrendered all of the share options previously held by them. A proportion of these options had been issued under the Company's EMI Scheme and would thus have benefitted the Executive Directors with favourable tax treatment.

The surrender of these options by the Executive Directors was done in good faith and resulted in the cancellation of the historic share-based payment charges associated with them. As a consequence, the level of pre-tax profit achieved by the Company for the year ended 31 March 2021 was enhanced by approximately £400,000.

Notwithstanding the assurances that had been received, two of the Company's larger shareholders subsequently changed their minds and instead of voting in favour of the introduction of the proposed arrangements, voted against. Consequently, despite 66.4% of the shareholder votes received being in favour, the resolution failed to gain a sufficient level of support for it to be passed as a special resolution.

The rejection of an alternative incentive arrangement has obliged the Company to revert to the use of share options as a means of incentivising and rewarding the Executive Directors and other senior managers.

Related Party Transaction

Oliver Cooke and Brian Raven have been granted options over 30,000,000 and 40,000,000 shares respectively. The number of options, together with the exercise price, were determined so as to replace the options surrendered by them in good faith and to compensate them for the loss of tax sheltering which applied to a proportion of the options they previously held. Any potential gain on the new options will fall to be taxed at 45% rather than the 10% rate of tax that would have applied to the options under the Company's EMI scheme.

As the grant of options to the Directors constitutes a related party transaction under the AIM Rules, the independent directors, being Roderic Rennison and Peter Dornan, having consulted with the Company's nominated adviser, Allenby Capital Limited, consider the terms of the grant of options are fair and reasonable in so far as the Company's shareholders are concerned.

 

 

Enquiries:

 

Tavistock Investments Plc Tel: 01753 867000

Oliver Cooke

Brian Raven

 

Allenby Capital Limited

(Nominated Adviser and Broker to Tavistock) Tel: 020 3328 5656

Corporate Finance:

Nick Naylor, Nick Athanas, Liz Kirchner

Sales and Corporate Broking:

Tony Quirke

Powerscourt (PR adviser to Tavistock) Tel: 07711 380 007

Gilly Lock 020 7250 1446

Chloe Retief

 

 

The notifications below, made in accordance with the requirements of the UK Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 Brian Raven

2

Reason for the notification

 PDMR

a)

Position/status

 Chief Executive

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tavistock Investments Plc

b)

LEI

 21380078QEABEGTVT16

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

 Ordinary Shares of £0.01 each

 ISIN: GB00BLNMLS43

b)

Nature of the transaction

Grant of options over Ordinary Shares

c)

Price(s) and volume(s)

Price: 5.25p

Volume: 40,000,000

d)

Aggregated information

- Aggregated volume

- Price

 n/a

e)

Date of the transaction

15 June 2021

f)

Place of the transaction

Outside of a trading venue

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 Oliver Cooke

2

Reason for the notification

 PDMR

a)

Position/status

 Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tavistock Investments Plc

b)

LEI

 21380078QEABEGTVT16

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

 Ordinary Shares of £0.01 each

 ISIN: GB00BLNMLS43

b)

Nature of the transaction

Grant of options over Ordinary Shares

c)

Price(s) and volume(s)

Price: 5.25p

Volume: 30,000,000

d)

Aggregated information

- Aggregated volume

- Price

 n/a

e)

Date of the transaction

15 June 2021

f)

Place of the transaction

Outside of a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGMVMKZGMZM
Date   Source Headline
8th Jan 20247:00 amRNSDirector/PDMR Shareholding
4th Jan 20249:33 amRNSDirector/PDMR Shareholding
19th Dec 20237:00 amRNSInterim Results
1st Nov 202312:25 pmRNSResult of AGM
18th Oct 20234:58 pmRNSNotice of AGM
5th Oct 20237:00 amRNSTrading update and interim dividend declaration
20th Sep 20237:00 amRNSFinal Results for Year Ended 31 March 2023
28th Apr 20235:00 pmRNSTotal Voting Rights
11th Apr 20237:00 amRNSAcquisition of Precise Protect Limited
1st Mar 20237:00 amRNSTotal Voting Rights
16th Feb 20231:45 pmRNSExercise of Options and Total Voting Rights
10th Feb 20237:00 amRNSChange of Auditor
26th Jan 20237:00 amRNSDirector appointment
20th Dec 20227:00 amRNSInterim Results
1st Dec 20227:49 amRNSSale of LEBC Hummingbird Limited
30th Nov 20225:00 pmRNSTotal Voting Rights
22nd Nov 202212:30 pmRNSBuyback shares cancelled
18th Nov 20229:30 amRNSTransaction in Own Shares
4th Nov 202211:30 amRNSExercise of Options and Total Voting Rights
31st Oct 202212:00 pmRNSResult of AGM
6th Oct 20227:00 amRNSNotice of AGM
30th Sep 20225:00 pmRNSTotal Voting Rights
28th Sep 20227:00 amRNSPosting of Annual Report and Accounts
26th Sep 20227:00 amRNSFinal Results for Year Ended 31 March 2022
2nd Sep 202212:49 pmRNSExercise of Options and Total Voting Rights
31st Aug 20225:00 pmRNSTotal Voting Rights
24th Aug 20222:14 pmRNSBuyback shares cancelled
17th Aug 202210:41 amRNSTransaction in Own Shares
16th Aug 202210:14 amRNSDirector/PDMR Shareholding
26th Jul 202211:50 amRNSDirector/PDMR Shareholding
26th Jul 202210:33 amRNSDirector/PDMR Shareholding
12th Jul 20223:42 pmRNSHolding(s) in Company
12th Jul 20221:10 pmRNSHolding(s) in Company
4th Jul 202211:56 amRNSDirector/PDMR Shareholding
30th Jun 20226:29 pmRNSTotal Voting Rights
30th Jun 20222:20 pmRNSDirector/PDMR Shareholding
29th Jun 20222:22 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update and interim dividend declaration
23rd Jun 20222:04 pmRNSExercise of Options and Total Voting Rights
23rd May 20227:00 amRNSAcquisition of LEBC Hummingbird Limited
10th May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSCompletion of purchase of minority holding in LEBC
31st Mar 20225:00 pmRNSTotal Voting Rights
21st Mar 20227:00 amRNSTotal Voting Rights & AIM Rule 17
17th Mar 20227:00 amRNSHolding(s) in Company
28th Feb 202211:06 amRNSSecond Price Monitoring Extn
28th Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Feb 202211:06 amRNSSecond Price Monitoring Extn
11th Feb 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.